These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5032677)

  • 1. Hypotensive effect of methyldopa in renal failure associated with hypertension.
    Stenbaek O; Myhre E; Brodwall EK; Hansen T
    Acta Med Scand; 1972 Apr; 191(4):333-7. PubMed ID: 5032677
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of methyldopa on renal function in patients with renal insufficiency.
    Brodwall EK; Myhre E; Stenbaek O; Hansen T
    Acta Med Scand; 1972 Apr; 191(4):339-41. PubMed ID: 5032678
    [No Abstract]   [Full Text] [Related]  

  • 3. High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
    Rastogi SP; Volans G; Elliott RW; Eccleston DW; Ashcroft R; Webster D; Kerr DN
    Postgrad Med J; 1971 Apr; 47():Suppl:45-53. PubMed ID: 5579771
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report on the clinical testing of the Sembrina--Saltucin. Drug combination for the treatment of hypertension].
    Holler HD; Steinorth G
    Med Welt; 1969 Oct; 42():2306-14. PubMed ID: 5355675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertension in renal failure].
    Brodwall EK; Myhre E; Stenbaek O
    Tidsskr Nor Laegeforen; 1972 Apr; 92(10):707-8. PubMed ID: 5028421
    [No Abstract]   [Full Text] [Related]  

  • 7. Myopathy in chronic renal failure.
    Floyd M; Ayyar DR; Barwick DD; Hudgson P; Weightman D
    Q J Med; 1974 Oct; 43(172):509-24. PubMed ID: 4462721
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral diazoxide contraindicated in severe hypertension with renal failure.
    Mussche MM; De Broe ME; Belpaire FM; Vermeulen A; Ringoir SM
    Clin Nephrol; 1975; 4(3):99-103. PubMed ID: 810287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
    Nestor G; Beroniade V; Tutunaru M
    Med Interna (Bucur); 1970 Jul; 22(7):863-8. PubMed ID: 5479504
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of renal hypertension with alpha-methylodopa (Presinol) and Cyclazenin (Leron)].
    Sarre H; Oechslen D
    Med Klin; 1967 Apr; 62(14):561-5. PubMed ID: 5592469
    [No Abstract]   [Full Text] [Related]  

  • 13. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of arterial hypertension with alpha-methyldopa].
    Herteanu H; Bucur V
    Med Interna (Bucur); 1969 Sep; 21(9):1119-26. PubMed ID: 5378243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alphamethyldopa-induced hyperprolactinemia, amenorrhea, galactorrhea syndrome in chronic kidney failure].
    Szücs J; Csillag J
    Orv Hetil; 1982 May; 123(20):1241-2. PubMed ID: 7202173
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical results of therapy with alpha methyldopa, specially of its effect on the potassium content of serum and on the kidney function].
    Paquet KJ; Blittersdorf F
    Med Welt; 1967 Apr; 13():794-8. PubMed ID: 5584456
    [No Abstract]   [Full Text] [Related]  

  • 17. Conjugation of methyldopa in renal failure.
    Myhre E; Stenbaek O; Brodwall EK; Hansen T
    Scand J Clin Lab Invest; 1972 Apr; 29(2):195-9. PubMed ID: 5029323
    [No Abstract]   [Full Text] [Related]  

  • 18. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G; Ducrot H; Hamburger J; Legrain M; Maxwell M; Péquignot MH
    Presse Med (1893); 1968 Nov; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract]   [Full Text] [Related]  

  • 19. The renal excretion of methyldopa.
    Myhre E; Brodwall EK; Stenbaek O; Hansen T
    Scand J Clin Lab Invest; 1972 Apr; 29(2):201-4. PubMed ID: 5029324
    [No Abstract]   [Full Text] [Related]  

  • 20. [Propranolol in the control of arterial hypertension in patients with chronic renal insufficiency].
    De Sancho JL; Muñíz R; Gómez-Ullate P; Orofino L; Villar F; Lampreabe I; García Damborenea R
    Rev Clin Esp; 1975 Apr; 137(2):145-50. PubMed ID: 1144843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.